Home/ Stocks/ NXTS

Nexentis Technologies Inc. Common Stock

NXTS XNAS

$1.93 +0.07 (+4.05%) ▲ 15-min delayed

Open

$1.98

High

$2.01

Low

$1.88

Volume

20.5K

Market Cap

$2.69M

About Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 9 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	N/A	$-6,589,000	$-10.74

TickerDaily Coverage

Why Is Nexentis Technologies Inc. Common Stock (NXTS) Stock Up 177.2% Today?

Market News Alex Chen · Jun 22, 2026

Nexentis Technologies Inc. Common Stock (NXTS) exploded higher Monday, gaining 177.2% to $14.08 on...

Stock Market Today, June 26, 2026: Penny Stock Surge Dominates Week as Broader Indices Stabilize

Market News David Brooks · Jun 26, 2026

The stock market today, Friday, June 26, 2026, closes a week defined by extreme volatility in...

View All Coverage →

Get NXTS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Nexentis Technologies Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.